Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Derick Chae

Psychosomatic Medicine Honolulu, HI Medical Doctor

NPI 1871709451 CMS profile 786732

1356 Lusitana St, Department Of Psychiatry 4Th Floor, Honolulu, HI 96813

Open in the dashboard

General payments

$7,993

170 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Derick Chae of Honolulu, HI is reported in the CMS Open Payments database as having received $7,993 across 170 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Psychosomatic Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $883 8
2024 General $1,724 26
2023 General $557 20
2022 General $2,293 73
2021 General $1,743 36
2020 General $118 1
2019 General $675 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derick Chae
  • Psychosomatic Medicine median
  • Middle half of Psychosomatic Medicine
  • National median

In program year 2025, general payments to Derick Chae were reported at $883. Among 72 Psychosomatic Medicine profiles paid that year, the median was $152 and the middle half received between $47 and $428.

Show as a table
Year Derick Chae Psychosomatic Medicine median Middle half National median
2019 $675 $125 $51–$524 $163
2020 $118 $117 $29–$251 $114
2021 $1,743 $123 $33–$366 $132
2022 $2,293 $107 $37–$450 $149
2023 $557 $131 $57–$397 $160
2024 $1,724 $122 $27–$293 $164
2025 $883 $152 $47–$428 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Teva Pharmaceuticals USA, Inc. $2,301 35 payments
  2. Alkermes, Inc. $1,062 24 payments
  3. Neurocrine Biosciences, Inc. $752 13 payments
  4. Otsuka America Pharmaceutical, Inc. $686 19 payments
  5. Sunovion Pharmaceuticals Inc. $657 25 payments
  6. Janssen Pharmaceuticals, Inc $558 14 payments
  7. ITI, Inc. $489 7 payments
  8. Axsome Therapeutics, Inc. $358 3 payments
  9. AbbVie, Inc. $339 3 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $213 15 payments
  11. Other $578 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,942 168 payments
  2. Education $50 2 payments
Products named General payments · program years 2019–2025
  1. AUSTEDO $838 19 payments
  2. Austedo XR $805 9 payments
  3. LYBALVI Cns $706 20 payments
  4. UZEDY $658 7 payments
  5. LATUDA $657 25 payments
  6. ARISTADA Cns $643 20 payments
  7. ARISTADA Cns $643 20 payments
  8. INGREZZA $632 12 payments
  9. LYBALVI Cns $567 14 payments
  10. ARISTADA INITIO $505 14 payments
  11. Other $5,345 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychosomatic Medicine in Hawaii

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record